Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms

Table 9 Immunity changes in SAP cases of two groups before and after therapy (¯x±s)

	Treatment group (n = 7)		Control group (n = 7)
	Before therapy	After therapy	Before therapy	After therapy
P-VC (μmol/L)	31.93 ± 7.21	49.27 ± 10.12a	32.89 ± 2.17	38.17 ± 9.41a
CD3 (%)	45.65 ± 11.18	51.39 ± 7.17	44.90 ± 10.47	47.45 ± 10.72
CD4 (%)	22.48 ± 6.35	36.93 ± 8.51a	23.85 ± 7.52	25.67 ± 7.57a
CD8 (%)	23.32 ± 6.43	23.64 ± 5.50	26.84 ± 5.92	22.58 ± 6.74
CD4/CD8	0.85 ± 0.23	1.41 ± 0.47a	0.86 ± 0.45	1.17 ± 0.52a

Before therapy: P > 0.05 vs the two groups. After therapy:

^aP < 0.05 vs the two groups.